U.S. markets close in 49 minutes
  • S&P 500

    4,516.54
    +30.08 (+0.67%)
     
  • Dow 30

    35,423.44
    +164.83 (+0.47%)
     
  • Nasdaq

    15,123.35
    +101.54 (+0.68%)
     
  • Russell 2000

    2,274.52
    +6.68 (+0.29%)
     
  • Crude Oil

    82.94
    +0.50 (+0.61%)
     
  • Gold

    1,770.70
    +5.00 (+0.28%)
     
  • Silver

    23.73
    +0.47 (+2.00%)
     
  • EUR/USD

    1.1640
    +0.0022 (+0.19%)
     
  • 10-Yr Bond

    1.6340
    +0.0500 (+3.16%)
     
  • GBP/USD

    1.3798
    +0.0071 (+0.51%)
     
  • USD/JPY

    114.3140
    +0.0020 (+0.00%)
     
  • BTC-USD

    63,623.14
    +2,100.78 (+3.41%)
     
  • CMC Crypto 200

    1,472.88
    +9.52 (+0.65%)
     
  • FTSE 100

    7,217.53
    +13.70 (+0.19%)
     
  • Nikkei 225

    29,215.52
    +190.06 (+0.65%)
     

Accolade to Announce Fiscal Second Quarter 2022 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Conference Call Details

The conference call can be accessed by dialing 1-833-519-1281 for U.S. participants, or 1-914-800-3853 for international participants, referencing conference ID # 9547326; or via a live audio webcast that will be available online at http://ir.accolade.com.

A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Accolade, Inc.

Accolade provides personalized health and benefits solutions designed to empower every person to live their healthiest life. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians, and access to expert medical opinion services and virtual primary care. Accolade consistently receives consumer satisfaction ratings over 90 percent. For more information, visit Accolade on LinkedIn, Twitter, Instagram and Facebook and at accolade.com.

Investor Contact:

Todd Friedman, Investor Relations, 484-532-5200, IR@accolade.com

Asher Dewhurst, Investor Relations, 443-213-0500, accolade@westwicke.com

Media Contact:

Megan Torres, Public Relations, 206-926-8180, media@accolade.com

Source: Accolade